Published 2022 | Version v1
Publication

1476P Immunohistochemical (mIHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: Main results from the Meet-URO 18 study

Additional details

Created:
February 4, 2024
Modified:
February 4, 2024